Funded research

Supporting research in the field of infection prevention and control (IPC) in healthcare has been a key HIS activity since 1986, when the first scholarships to support visits to overseas laboratories and organisations were awarded.

Since then, HIS has maintained a designated fund to support a variety of research and funding.

The level of funding is decided by HIS Council, and may vary from year to year depending on the quality of applications received and the overall financial position of the Society. Currently, all grants are restricted to research undertaken in UK and Eire.

We have regularly awarded funding of up to £99,000 for Major Research Grants and we are proud of our contribution to both the development of evidence in the field of infection prevention, and the support of the professional development of our members.

Below we have detailed the research we have funded, and we have included highlights from some of our grant holders.

Further information about our grants programme is available here

Current Projects

Major Research Grants


Dr Ross Lathan, Vascular Research Lab, Hull Royal Infirmary

"The DRESSINg trial: A multicentre randomised controlled trial to assess the effectiveness of Dialkylcarbamoylchloride (DACC) coated post- operative dressings versus standard care in the prevention of Surgical Site Infection in clean or clean contaminated vascular surgery"

This study aims to investigate the role of a bacterial binding dressing (DACC) in preventing wound infection, following vascular surgery. The DACC dressing irreversibly binds bacteria to its surface, allowing them to be removed from around the wound. This dressing will be compared to standard dressings (that simply cover the wound) that are currently applied after surgery.

Surgery on arteries or veins (vascular surgery) is common, with over 200,000 operations annually in the UK. For every 100 patients undergoing vascular surgery, up to 40 may develop a wound infection. In other types of surgery only 5 in every 100 patients would develop infection. This is because patients needing vascular surgery are elderly, frail and have other conditions such as diabetes or cigarette smoking, which all increase their risk of problems after the operation. Every wound infection is distressing, causing pain, reduced mobility, extended hospital stays and scarring. Unfortunately, these infections also increase the risk of losing limbs, and death. Studies show that DACC dressings are safe, suitable and acceptable to vascular surgical patients. These dressings may reduce the risk of infection, but are more expensive than standard dressings. However, wound infections result in high financial cost to the NHS (over £6,000 per infection) so a large scale research trial is needed to ensure DACC reduces wound infection without substantial cost to the NHS.

We have designed a study where 720 participants undergoing vascular surgery will be randomly allocated to receive either a DACC coated dressing or standard care. We will assess the impact of these dressings on rates of wound infection at 30 days.

We expect that this study will establish whether DACC dressings are effective at reducing wound infections after surgery. We will also understand if in doing so, these dressings are effective at reducing the overall cost of treating these patients.


Dr Andrew Kirby, The University of Leeds

"Colo-Pro_2: A feasibility randomised controlled double-blind trial to compare standard bolus dosed cefuroxime prophylaxis to bolus-continuous infusion dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery"

Aims: We want to stop the infections patients suffer after bowel (gut) operations.

Background: Patients in hospital can have operations as part of their care. After a surgical operation patients may have an infection in the operation wound, the bladder, kidneys or lungs. To stop these infections patients are given a dose of antibiotic before their operation. Unfortunately, the amount of antibiotic available to fight infections falls throughout an operation, being removed from the body by the kidneys. Therefore, antibiotic levels may not be high enough to stop infections. A way of maintaining antibiotic levels throughout an operation is to give a single dose of antibiotic and then a constant amount of antibiotic by an infusion from the start to the end of the operation. The World Health Organisation recommends trials be completed to find the best way of dosing antibiotics during operations to stop infections. We previously carried out a small single centre test study into antibiotic dosing during bowel operations. One group of patients had a single dose of antibiotic before their operation. The other group had a single dose plus a constant dose of antibiotic until the end of their operation. The project showed patients were happy to take part and that the study was safe. The study helped us identify the correct amounts of antibiotic needed for the patients given the single dose plus a constant dose of antibiotic. This study was conducted at one hospital only, and wasn’t big enough to confirm if one treatment was better than another or if results would be similar in other hospitals.

Design and methods: We will build on the pilot study in a larger feasibility trial, the Colo-Pro_2 trial. It will be run in three hospitals so we can show our methods work at different hospitals. We will see if the results suggest one treatment, single dose of antibiotics before an operation, or single dose plus a constant dose of antibiotics throughout an operation, is better. We will study this in a trial of 180 patients having bowel operations as they have a high risk of infection. All patients will be given the same antibiotic which is called cefuroxime. Cefuroxime is already used to stop infections after surgery. Using the same antibiotic in all patients means we can tell if differences in the number of infections are due to how we give the antibiotic. We will count the infections that happen up to 30 days after operations. We will make sure staff looking after patients after the operation and those counting the infections do not know, unless necessary, the treatment patients received. This means our results won’t be influenced by knowledge of the treatment received.  

Patient and public involvement (PPI): A PPI group helped design our pilot and will advise on trial conduct and sharing of results.

Dissemination: Anonymous results will be shared in journals, at national/international conferences and on social media.


Dr Lena Ciric, University College London   

"Developing hospital surface sampling protocols for better IP&C" - PhD studentship 

Hospital surfaces are often contaminated with dangerous bacterial, fungal and viral organisms that can cause harm to patients. Patients who are particularly unwell are at the highest risk of infection because their immune system is likely to be compromised. Microbes within hospitals are also more likely to be resistant to treatment like antibiotics, so preventing infections caused by such organisms is very important. There are many studies on how hand washing can help prevent the spread of infectious microbes between patients. There is also guidance for hospital staff on when and how to wash their hands. However, there is no guidance on how to sample hospital surfaces. In the past, hospital surfaces were not thought to play a role in the spread of infectious microbes. However, more recently, many studies have found dangerous microbes on hospital surfaces, but none have linked this to the risk of infection in patients. These studies have also been done many in different ways so it is impossible to compare them directly or draw conclusions.

The aim of this project is to collect evidence that will lead to the design of surface sampling methods that can be suited to any hospital. The methods designed will vary in cost and the time, as well as the level of detail in the results. However, all the methods will be able to uncover the level of risk the surfaces may pose to patients. The first step in the project will be to collect many samples from different surfaces in the hospital. This will be done in four different types of wards in Great Ormond Street Hospital every month for one year. The samples will be taken at various locations (e.g. near the patients, far from the patients, in the staff areas, from different materials, etc). The samples will be screened for the presence of bacterial, fungal and viral pathogens and antimicrobial resistance. DNA-based methods will also be used to look at the whole communities present on the surfaces, not just those organisms that can grow on microbiological media. In parallel, data will be collected about how the surfaces sampled were cleaned. In addition, information about infections that patients had in the sampled areas will also be collected. Finally, all of this data will be combined to find trends and show which surface samples are the most important ones to take.

To make useful training and guidance materials, the project team will consult with clinicians, cleaners, patients and their parents to find out what they know about the risk the hospital environment can pose to patient health. This will be done though informal conversations, workshops and questionnaires and will be used to help to produce guidance to inform policy groups such as NICE, design training for hospital staff and cleaners and materials to help inform patients and the public. The project will take a systematic approach in order to collect evidence on how best to carry out hospital surface sampling leading to better practice and, consequently, better patient outcomes.

Small Research Grants


Major (Dr) Scott John Charles Pallett RAMC, Department of Clinical Microbiology Frimley Park Hospital

"Multi-drug resistant organism carriage & transmission from citizens in conflict zones (MDRO-AGAMEMNON)"

The World Health Organisation considers antimicrobial resistance to be among the top ten threats to global health. Disaster situations, such as earthquakes, tsunamis or the outbreak of human conflict can accelerate the spread of antimicrobial resistance.

In the event of disaster situations, access to clean water and healthcare including surgery, laboratory testing services and antibiotics themselves can be severely affected. This presents significant challenges to doctors and nurses seeking to treat associated infections. These situations often see displacement of a large number of the population to temporary accommodation within the country affected as well as neighbouring countries. Where injured people may need further healthcare there is a considerable risk of these very resistant organisms spreading further and challenging early treatment of any infections.

Ukraine has seen widespread human conflict since March 2022 and considerable damage to its healthcare, water, hygiene and sanitation infrastructure. Data is very limited but what we have been able to collect suggests that the conflict has drastically accelerated the spread of infections that are resistant to multiple antibiotics. We do not know whether risk of these very resistant bacteria is tied come after hospital admission in temporary healthcare conditions or whether the damage to hygiene infrastructure may mean the risk is high at first presentation to hospital. This makes it difficult to know how to manage early wounds that may have been infected.

This study will work with Ukrainian nationals to provide the first insights to the carriage of resistant bacteria prior to hospital admission. The findings will help better understand the risk of transmitting these resistant bacteria on admission to UK hospitals after travel from Ukraine with conflict-related injuries. It will also help guide the best choice of antibiotics for use in early management of infected wounds.

Graham Ayliffe Training Fellowship


Dr Simon Pybus, NHS Scotland Assure Antimicrobial Resistance & Healthcare Associated Infection (ARHAI) Scotland and Assurance Service

"Joint fellowship on prevention, surveillance and control of infection in the built environment in NHS Scotland Assure"

This fellowship project aims to develop local specialist skills in prevention of infections acquired from the healthcare environment, in addition to skills in systematic monitoring of infection data to help early outbreak detection and control. Simon is a medical doctor in specialist training in medical microbiology and infectious diseases, and has a keen interest in IPC. Medical microbiologists are key members of IPC teams in hospitals who offer a unique perspective with clinical and laboratory input.

This is a one-year career fellowship to develop specialist skills in prevention of infections associated with the built environment in healthcare settings. Patients have a right to receive healthcare in a safe environment but microorganisms in the building may present a threat to this, including those in air and water. Managing risk depends on individual patient susceptibility to infection and particular scenarios which need to be avoided. For example, it is critical that air is free of microorganisms in an operating theatre where knee replacements are performed to prevent contamination of an open surgical site. Another example is an intensive care unit where it is essential handwash basins cannot splash onto sterile equipment which may make its way to the patient. Protecting patients from these risks starts at the design process and continues through construction and maintenance. Designing healthcare settings to minimise risk is complex, however designing a new hospital is often considered a once in a career project. There is an argument for development of greater subspecialist expertise to make this process safer.

The year will be spent working within NHS Scotland Assure Antimicrobial Resistance & Healthcare Associated Infection (ARHAI) Scotland and Assurance Service. NHS Scotland Assure is a new organisation set up to reduce risks of the healthcare environment across Scotland. NHS Scotland Assure is part of National Services Scotland (NSS) and houses ARHAI Scotland, Health Facilities Scotland as well as the new assurance service.  ARHAI Scotland is a well-established organisation which collects and analyses data on infections nationally and produces evidence-driven guidance with the aim to reduce the burden of healthcare-associated infections. Within the Assurance Service, the fellow will work with design teams, attend multidisciplinary team meetings with staff in estates and maintenance, review plans for building works and renovations from an infection prevention viewpoint, and gain experience in clinical interpretation of technical requirements and implementation of design to control infection risks from the healthcare environment. At ARHAI Scotland, the fellow will learn skills in data analysis, monitoring of infection rates and types, and ultimately work on appraising available data and studies to contribute to national guidance. It is envisaged that working across NHS Scotland Assure will expand local skills in the important interface between technical commissioning, infection prevention in the healthcare environment and surveillance to recognise and control risks and outbreaks.

Pilot Project Grant


Dr Blair Merrick, St Thomas’ Hospital

"Can lyophilised encapsulated FMT improve gut barrier integrity in subjects colonised with multi-drug resistant organisms compared to placebo-controlled subjects?"

When antibiotic resistant bacteria (ARB) cause infections they are often difficult to treat and are associated
with worse clinical outcomes. Before causing infections, ARB are often found in peoples’ gut (colonisation).
Here ARB live harmlessly alongside other gut organisms (the microbiota). Unfortunately, ARB can escape
from the gut, leading to infections elsewhere in the body.

A healthy gut microbiota may be able to reduce the likelihood that ARB escape from the gut. One of the
ways they may do this is by keeping the barrier between the gut and the rest of the body intact.
Unfortunately, in some people the microbiota and gut barrier are damaged, meaning they don’t function
as they should.

If this damage was repaired, we may be able to reduce infections by ARB. Faecal microbiota transplantation
(FMT) – the process by which stool from healthy donors is turned into a drug treatment and given to
patients to improve their health – may be able to do this.

We have undertaken a clinical trial recruiting participants with a history of infection with ARB and who are
colonised with ARB to receive, at random, FMT, or a placebo (dummy medication). We would like to test
their stool samples to see if FMT has been able to repair their gut barrier.


Professor Lesley Hoyles, Nottingham Trent University

"Investigating the influence of physiologically relevant cultivation conditions on biofilm formation by bacteria associated with catheter infections"

One of the James Lynd Alliance priorities relates to decreasing the development and severity of urinary tract infections (UTIs) in the elderly. While the recent Public Health England ‘Exploring the implementation of interventions to reduce catheter associated urinary tract infections (ENACT)’ report has addressed behavioural changes that can be made in hospital settings to reduce incidences of UTIs, the microbiological processes associated with UTIs remain poorly studied.

Much of the microbiological work undertaken in this area relies on growth conditions that are physiologically irrelevant, likely influencing the translational potential of many research outputs. Systems-level work in metabolic diseases has shown that host-microbiota interactions and microbially produced metabolites influence disease progression.

There is a need to consider UTIs in a similarly holistic manner. Better understanding of how bacteria 1) form biofilms in the urinary tract, 2) metabolize components of urine and 3) influence biological functions in the urinary tract will lead to better understanding of infection initiation and progression, and ultimately to identification of novel therapeutic agents to prevent or reduce severity of UTIs.

The aims of this project are 1) to understand the influence of oxygen conditions and physiologically relevant growth substrates on the ability of CAUTI bacteria to form biofilms, and 2) to begin to define the CAUTI metabolome.

Completed research

Major Research Grant


Professor Heather Loveday, University of West London

"Preventing non-ventilator hospital-acquired pneumonia: the PRHAPs Study" 


Dr Nicola Irwin, Queen's University Belfast

"Combatting device-associated, healthcare-associated infections with innovative, anti-biofouling, anti-blocking and non-resistance-promoting technologies"

Dr Ginny Moore, Public Health England

"Mycobacterium chimaera contamination of heater-cooler units: a hybrid product of water and engineering"


Dr Caroline Chilton, University of Leeds

"Development of a rapid, cost effective algorithim to improve detection of intestinal carbapenemase producing Enterobacteriaceae"


Dr Michael Prentice, University College Cork

"Real-time Monitoring of Biological Airborne Particles in the Hospital Environment (ReM-BAPHE)"


Prof Jean-Yves Maillard, Cardiff University

"Effect of commonly used antimicrobial biocides in healthcare"


Dr Jimmy Walker, Public Health England

"Impact of tap design on Pseudomonas aeruginosa biofilm formation and presence of other waterborne nosocomial pathogens"


Dr Edward Cartwright, University of Cambridge

Improving the detection of MRSA transmission events: a comparison of automated patient location data plus antimicrobial susceptibility patterns compared to whole genome sequencing"


Dr Eoghan O'Neill, Beaumont Hospital, Dublin

"Investigation of novel therapeutics to prevent and treat intravascular catheter infections caused by staphylococci using a combination of in vitro and animal models"


Dr John Edmunds, London School of Hygiene and Tropical Medicine

Modelling the population-level and cost-effectiveness of Clostridium difficile vaccination as part of an integrated healthcare associated infection prevention and control strategy.”


Dr Thomas Smith, Sheffield Hallam University

Molecular microbial ecology of hospital ward environments: a new tool to understand the role of the environment in HAIs.”

Dr David Tetard, Northumbria University

Synthesis and study of iron(iii) strong chelator as antimicrobial supplements to inhibit the growth of pathogenic bacteria on hospital equipment and hard surfaces.


Dr B V Jones, University of Brighton

"Elucidation of mechanisms required for the pathogenesis of Proteus mirabilis in the catheterised urinary tract through large scale random transposon mutagenesis."


Professor Peter Griffiths, King's College London, University of London

"’Somebody else’s problem’: a study to identify and determine the significance of attributional bias in the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) healthcare settings.”

Dr Jacqueline Randle, The University of Nottingham

Involving patients and visitors in reducing Clostridium difficile cross-transmission via the use of technologies.”


Dr Dietrich Mack, The University of Wales, Swansea

"Quorum-sensing accessory gene regulator (agr)-specificity groups in Staphylococcus epidermidis strains isolated from prosthetic hip and knee joint and catheter infections."


Dr Jean Yves Maillard, Welsh School of Pharmacy

"Surveillance of antiseptic susceptibility profile of Staphyloccocus aureus ITU isolates including MRSA."


Small Research Grant


Dr Sarah Fieldhouse, Staffordshire University

"A preliminary and comparative study of filtered light analysis and ATP testing for infection monitoring in an NHS hospital"

Dr Catherine Houlihan, Rare and Imported Pathogens Laboratory, UK Health Security Agency

"Monkeypox virus culture from longitudinal samples from 7 patients to determine risk of onwards transmission"


Dr Harry Dean, St Marks Hospital & Academic Institute, Northwick Park Hospital

"Prospective Bacteriology of Surgical Site Infection Following Surgery for Intestinal Failure"


Dr Kate Walker, University of Nottingham

"Maternity services response to the COVID-19 pandemic: how PHE guidance was implemented and what we can learn for the future"


Dr Sarah Forbes, Sheffield Hallam University     

"Transcriptomic analysis of biocide adaptation in uropathogenic Escherichia coli CFT073"


Dr Felicity Fitzgerald, UCL Great Ormond Street and Institute of Child Health, London

"Reducing mortality from neonatal sepsis: a pilot mixed-methods approach in Zimbabwe"


Dr Katie Hardy, Public Health Laboratory, Birmingham

"Attack of the clones? Implementation of whole genome sequencing to determine spread of vancomycin-resistant Enterococcus faecium in a high-risk healthcare setting."


Dr Matthew Scarborough, Oxford University Hospitals

"Reducing Implant Infection in Orthopaedics (RIIi0) Pilot Study"

Professor Jean-Yves Maillard, Cardiff University

"Seeking dry surface biofilm in healthcare environments; is this a reservoir for multi drug resistant pathogens?"  

Dr Shanom Ali, University College  London Hospital

"Discovery of compounds with the potential to disrupt biofilm-formation on medical devices and surfaces colonised with antimicrobial-resistant bacteria"


Prof Peter Hawkey, University of Birmingham

The molecular epidemiology of CTX-M antibiotic resistance genes and the faecal microbiome of humans acquiring ESBL - producing Enterobacteriaceae.”

Dr Ed Moran, Heart of England NHS Foundation Trust

The Impact of community antibiotic treatment.”


Dr Katie Hardy, Public Health Laboratory Birmingham

"Investigating and defining reduced susceptibility."

Prof Edward Feil, University of Bath

The development of a next-generation sequencing approach for inferring colonisation and transmission dynamics of multiple Staphylococcus spp. recovered from a burns unit.”

Dr Mathew Upton, Plymouth University

Investigating the role of healthcare workers in MRSA outbreaks using genome sequence analysis


Dr Nikunj Mahida, Nottingham University Hospitals

"Investigating the effect of clinical anaesthetic practice on bacterial contamination of intravenous fluids and drugs."

Dr Monika Muzslay, University College London Hospitals

"ESBL - producing Gram negative organisms in the healthcare environment as a source of genetic material for resistance in human infections."


Dr Alice M Turner, University of Birmingham

"Use of early mobilisation to reduce incidence of hospital acquired pneumonia in medical inpatients."

Dr Micheál Mac Aogáin, Trinity College Dublin

"Molecular epidemiology and transcriptome sequencing of Irish Clostridium difficile isolates to investigate gene expression patterns associated with disease severity."

Dr Cariad Evans, Sheffield Teaching Hospitals NHS Foundation Trust

"The molecular epidemiology of RSV and Parainfluenza 3 in a bone marrow transplant unit: clinical, infection control and cost implications of nosocomial transmission."

Dr Andrew Conway Morris, University of Edinburgh

"Pan-bacterial PCR for rapid diagnosis of ventilator-associated pneumonia"


Dr Eftihia Yiannakis, Nottingham University Hospitals NHS Trust

Decontamination of the healthcare environment following outbreaks of Norovirus: chlorine-based cleaning versus hydrogen peroxide misting.”

Dr Shanom Ali, UCLH Environmental Research Laboratory

The in-use assessment of electrolysed-oxidizing (EO) water and chemically-generated hypochlorous acid (HA).”

Dr Eamonn Trainor, Royal Liverpool University Hospital

Norovirus shedding and infectivity in hospitalised adult patients with acute gastroenteritis – A Pilot study at the Royal Liverpool University Hospital (RLUH).”


Elaine Cloutman-Green, Great Ormond Street Hospital

Development of Adenovirus detection and typing systems to investigate the contribution of environmental contamination, cleaning and human behaviour in cross transmission.”

Ashley McEwan, Manchester Royal Infirmary

Multilocus variable number tandem repeat analysis (MLVA) for real-time investigation of Staphylococcus aureus transmission in the hospital setting.”

Dr Katherine Cartwright, Leicester Royal Infirmary

Why are there an increasing number of Klebsiella pneumoniae bloodstream infections in Leicestershire? A combined case-control/molecular biological investigation.”


Dr Sue Lang, Glasgow Caledonian University

Mapping the dynamic transmission of Staphylococcus aureus in near patient areas of acute care wards.”

Dr Stephen Winchester, Kings College Hospital

A questionnaire based study of healthcare workers perceptions concerning occupational exposure to blood borne viruses and the possible barriers involved in reporting incidents.”

Dr Steve Green, Southampton General Hospital (HPA SW)

Longitudinal study of the molecular epidemiology and virulence of extended spectrum ß -lactamase-producing Escherichia coli (ESBL).”

Dr Ginny Moore, University College London Hospitals

Effect of disposable glove type upon the cross-transmission of methicillin-resistant Staphylococcus aureus.”


Dr Lindsay Parker, University Hospital Aintree

Use of probiotic yoghurt to prevent diarrhoea in critical care: a randomised double blind placebo controlled trial.”

Professor Jonathan Van-Tam, University of Nottingham

What is the association between specific infection control interventions and the incidence of HCAI?”

Professor Judith Tanner, De Montfort University

Patients’ preferences for hand washing interventions.”

Professor Mark Pallen, University of Birmingham

Translational genomics: next-generation genome sequencing as a tool to study the biology and epidemiology of Acinetobacter baumannii in an English teaching hospital.”


Dr A Galloway, Newcastle upon Tyne NHS Trust

Investigation of the value of monitoring serum galactomannan and (1,3)-ß D glucan in the early diagnosis of invasive fungal infection in immunocompromised patients during building work.”

Dr R Brady, University of Edinburgh

"Not to be sniffed at; Nasal MRSA colonisation in contemporary NHS doctors.”

Professor P O’Neill, Nottingham University

Mathematical and statistical modelling of multiply antibiotic-resistant pathogens in hospital settings.”


Dr R Brady, University of Edinburgh

Technological growth: Contamination of surgeon’s possessions with bacteria known to cause noscomial infection.”

Dr K Stephenson, University of Leeds

Spore formation and the responses of clinically significant Clostridium difficile strains to exposure to hospital decontamination and disinfection agents.”

Dr F Sundram, Royal Surrey County Hospital

“C. difficile ribotypes 027 and 106: Risk factors and clinical outcomes.”


Dr D Wareham, Queen Mary, University of London

Action of commercial alcohol handrubs on the growth and secretion of extracellular proteins from the Acinetobacter baumannii OXA-23 outbreak strain.”

Dr A Adedeji, Birmingham Children’s Hospital

MRSA in children presenting to hospitals in Birmingham: what might ‘community associated MRSA’ be?”

Dr G Phillips, Ninewells Hospital

Using compliance loggers to monitor the use of alcohol-based personal hand gels at Ninewells.”

Dr M Llewellyn, University of Sussex

Invasive Staphylococcus aureus infection; clinical outcomes and microbial epidemiology.”

Dr E Sheridan, Barts and The London Hospital

An analysis of space/time clustering of nosocomial infections in Intensive Care to identify key areas for Infection Control intervention.”

Graham Ayliffe Training Fellowship


Dr Razan Saman, St James University Hospital, Leeds [starts August 2021

Stategies to prevent transmission of Extended Spectrum Beta-Lactamase Enterobacterales


Dr Katie Prescott, Nottingham University Hospitals NHS Trust

Trainee Journal Editor and Trainee Infection Prevention and Control Doctor 

Dr Chris Lynch, Northern General Hospital, Sheffield

Trainee Journal Editor and theatre aspects of infection control


Dr Bozena (Jenny) Poller, Northern General Hospital

Design and establish a UK PPE Model and National PPE Simulation Program.


Dr Emma Wiley, University College Hospital London

Develop specialism in infection control with the aim to become a Consultant Microbiologist and Infection Control Doctor.


Dr Nikunj Mahida, Nottingham University Hospitals NHS Trust

Develop the skills and competencies to work as an assistant editor for JHI.

Dr Damian Mawer, Leeds Teaching Hospitals

Audit and practical IPC training/experience.


Dr Eftihia Yiannakis, Nottingham University Hospitals NHS Trust
Cystic fibrosis Centre

Environmental contamination by respiratory pathogens, infection control and guideline development.

Mike Emmerson Early Career Award


Dr Elaine Cloutman-Green, Great Ormond Street Hospital

Investigation of cross transmission by Enterobacteriaceae.”


Dr Vassiliki Dimou, Health Protection Agency

"Molecular epidemiology of carbapenem-resistant Enterobacteriaceae in a tertiary-care hospital."


Dr Simon Friar, Health Protection Agency Public Health Laboratory

"Molecular investigation of multi-drug resistant Enterobacter isolates, and screening of MDR coliforms for common resistance gene markers."


Mr Samford Wong, Buckinghamshire Healthcare NHS Trust

"Do probiotics prevent antibiotics associated diarrhoea in patients with spinal cord injuries: a randomised controlled trial."

Success and application rates

Major Research Grants

Over the last 5 years, 52 applications have been received and 6 grants have been awarded (success rate of 12%).

Small Research Grant

Over the last 5 years, 26 applications have been received and 7 applicants have been awarded a grant (success rate of 27%).

Graham Ayliffe Training Fellowship

Over the last 5 years, 13 applications have been received and 6 applicants have been offered a fellowship (success rate of 46%).

Pilot Project Grant

Over the last 4 years, 4 applications have been received and and 1 applicant has been awarded a grant (success rate of 25%).